Refine
Has Fulltext
- yes (124)
Is part of the Bibliography
- yes (124)
Year of publication
- 2021 (124) (remove)
Document Type
- Doctoral Thesis (123)
- Journal article (1)
Keywords
- Melanom (3)
- Angst (2)
- Angststörung (2)
- Arteriosklerose (2)
- Chlamydia trachomatis (2)
- Chromatin (2)
- DNA repair (2)
- Entzündung (2)
- Fluoreszenzmikroskopie (2)
- Fuchsbandwurm (2)
- Furcht (2)
- Furchtkonditionierung (2)
- G-Protein gekoppelte Rezeptoren (2)
- GPCR (2)
- Genetik (2)
- HUWE1 (2)
- Induzierte pluripotente Stammzelle (2)
- MAP-Kinase (2)
- MYC (2)
- MYCN (2)
- Maus (2)
- Mausmodell (2)
- Megakaryozyt (2)
- Multiple Sklerose (2)
- Multiples Myelom (2)
- Neisseria meningitidis (2)
- Neuroblastom (2)
- Neurodegeneration (2)
- Plasmozytom (2)
- Resistenz (2)
- Serotonin (2)
- Sphingolipide (2)
- Stammzelle (2)
- Thrombozyt (2)
- Tissue Engineering (2)
- Transcription (2)
- TrkB (2)
- Ubiquitin (2)
- Zellskelett (2)
- cAMP (2)
- cell wall (2)
- host-pathogen interaction (2)
- neuroblastoma (2)
- neuropathy (2)
- regulation (2)
- 177Lu-OPS201 (1)
- 3D models (1)
- 3D tissue model (1)
- 3D-Gewebemodell (1)
- 5`-UTR (1)
- 68Ga-OPS202 (1)
- 7T (1)
- ACC (1)
- ADGRL3 (1)
- ADHD (1)
- AI (1)
- ATF5 (1)
- ATGL (1)
- Acetylation (1)
- Acute myeloid leukemia (AML) (1)
- Adhesion GPCR (1)
- Adipose (1)
- Adipose-Derived Stromal/Stem Cells (1)
- Adrenalin (1)
- Adrenokortikales Karzinom (1)
- Advanced Therapy Medicinal Products (ATMP) (1)
- Adventitia (1)
- Agarose (1)
- Aiolos (1)
- Airway epithelia (1)
- Alzheimerkrankheit (1)
- Angstverhalten (1)
- Anthropocene (1)
- Anti-CD52-Antikörper (1)
- Antibody (1)
- Antigen CD44 (1)
- Antioxidantien (1)
- Aortenaneurysma (1)
- Arbeitsteilung (1)
- Arid biomes (1)
- Arrestine (1)
- Artesunate (1)
- Arzneimittel (1)
- Arzneimitteldesign (1)
- Arzneimittelzulassung (1)
- Aspergillus fumigatus (1)
- Atherosklerose (1)
- Aufmerksamkeit (1)
- Aufmerksamkeitsdefizit-Syndrom (1)
- Aurora-A (1)
- Aussterbedynamik (1)
- Autoantikörper (1)
- B cells (1)
- BDNF (1)
- BRCA1 (1)
- BTB domain (1)
- Bacillus subtilis (1)
- Bahnung (1)
- Bakterienzellwand (1)
- Basal Ganglia (1)
- Basalganglien (1)
- Bildanalyse (1)
- Biodistribution (1)
- Biogenese (1)
- Biolayerinterferometrie (1)
- Biologie (1)
- Bioluminescence resonance energy transfer (1)
- Biomarker (1)
- Biomaterial (1)
- Bioprinting (1)
- Bioreactor (1)
- Bioreaktor (1)
- Bitopic Ligands (1)
- Bitopische Liganden (1)
- Blickbewegung (1)
- Blickinteraktion (1)
- Blut-Rückenmarkschranke (1)
- Bordetella (1)
- Brain (1)
- Brain-derived neurotrophic factor (1)
- C. elegans (1)
- CCR4 (1)
- CD28 (1)
- CD28-SA (1)
- CD44 (1)
- CD84 (1)
- CDK4 Inhibitor (1)
- CDK4 inhibitor (1)
- CIDP (1)
- CMT1A (1)
- Caenorhabditis elegans (1)
- Camponotus rufipes (1)
- Candida albicans (1)
- Cardiac (1)
- Cardiomyocyte (1)
- Cartilage (1)
- Cartilage Tissue Engineering (1)
- Cataglyphis (1)
- Ccr4-Not (1)
- Celecoxib (1)
- Cell-Assisted Lipotransfer (1)
- Ceramide (1)
- Charcot-Marie-Tooth 1A (1)
- Chemotaxis (1)
- Chimeric antigen receptor (CAR) (1)
- Chimpanzee (1)
- Chronobiologie (1)
- Ciliary neurotrophic factor (1)
- Click-Chemie (1)
- Co-Kultur (1)
- Co-culture system (1)
- Cochlear-Implantat (1)
- Comoé National Park (1)
- Complement system (1)
- Conditioning (1)
- Cortico-striatal projection neurons (1)
- Craniosynostosis (1)
- Cushing-Syndrom (1)
- Cuticular transpiration (1)
- Cuticular waxes (1)
- Cyclo-AMP (1)
- Cystein (1)
- Cytoskeleton (1)
- DC (1)
- DNS-Reparatur (1)
- DOT1 (1)
- DTI (1)
- Danio rerio (1)
- Decapping (1)
- Deeplearning (1)
- Deletion (1)
- Dendritische Zelle (1)
- Depletion (1)
- Depression (1)
- Diabetes mellitus (1)
- Differential scanning calorimetry (1)
- Diffusionsgewichtete Magnetresonanztomografie (1)
- Drosophila (1)
- Drug resistance (1)
- Duplikation (1)
- E2 (1)
- ECAP (1)
- ECG-gated PET (1)
- EEG (1)
- Early-Life Stress (1)
- Echinococcus multilocularis (1)
- Effect anticipation (1)
- Effektantizipation (1)
- Einzelmolekülmikroskopie (1)
- Elektrostimulation (1)
- Entwicklung (1)
- Eosinophiler Granulozyt (1)
- Epigenetic (1)
- Epigenetik (1)
- Evolution (1)
- Expansion microscopy (1)
- Expansionsmikroskopie (1)
- Experimentelle autoimmune Enzephalomyelitis (1)
- Exposition (1)
- Expositionslernen (1)
- Expositionstherapie (1)
- Extinktion (1)
- Extracellular Vesicles (1)
- FLT3 inhibitor (1)
- FMS-like tyrosine kinase 3 (FLT3) (1)
- FRET (1)
- FT-IR-Spektroskopie (1)
- Ferroptosis (1)
- Fertilization in angiosperm (1)
- Fibromyalgia (1)
- Fibromyalgie (1)
- Fitness (1)
- Flavonoide (1)
- Flippase (1)
- Flow (1)
- Fluconazol (1)
- Fluconazole (1)
- Fluorescence correlation spectroscopy (1)
- Fluss (1)
- Folliculin (1)
- Foxo1 (1)
- Fragmentscreening (1)
- Functional analyses (1)
- Furagieraktivität (1)
- Furchtgeneralisierung (1)
- Förster Resonanz Energie Transfer (1)
- G glycoprotein (1)
- G-Protein gekoppelter Rezeptor (1)
- G-protein-coupled receptors (1)
- GMP (1)
- Gaze interaction (1)
- Gefäßwand (1)
- Gefäßwand-residente Stamm- und Vorläuferzellen (1)
- Gehirn (1)
- Gen BRCA 1 (1)
- Genetics (1)
- Genexpression (1)
- Genotoxicity (1)
- Genotoxizität (1)
- Genregulation (1)
- Gewebekultur (1)
- Glia (1)
- Glioblastom (1)
- Gliom (1)
- Glucose Starvation (1)
- Glutathion (1)
- Glycinrezeptor (1)
- Glycophyten (1)
- Glykomodifizierung (1)
- Glykosylierung (1)
- Gonococcal invasion (1)
- GvHD (1)
- H2A.Z (1)
- HECTD1 (1)
- HFpEF (1)
- Halophyten (1)
- Halophytes (1)
- Heart (1)
- Heart development (1)
- Heat stress (1)
- Helicobacter pylori (1)
- Herz (1)
- Herzinfarkt (1)
- Heubacillus (1)
- High-thropughput screening (1)
- Hippo pathway (1)
- Hippocampus (1)
- Hirnhaut (1)
- Histon-Methyltransferase (1)
- Histonacetyltransferase (1)
- Histone (1)
- Histone Acetylation (1)
- Histone modification (1)
- Histone variant (1)
- Hochauflösungsmikroskopie (1)
- Hochdurchsatz-Screening (1)
- Hornhaut (1)
- Huh6 (1)
- Human Transcriptome (1)
- Human-pathogenic (1)
- Hyaliner Knorpel (1)
- Hyaluronsäure (1)
- Hydrogel (1)
- Hypoxia (1)
- Hypoxie (1)
- Hämophilie A (1)
- Höhenangst (1)
- IKZF1 (1)
- IKZF3 (1)
- IRAK2 (1)
- Ideomotor gaze control (1)
- Ideomotorik (1)
- Ideomotorische Blickkontrolle (1)
- Ikaros (1)
- Immunological synapse (1)
- Immunozyt (1)
- Immunsystem (1)
- Immunzellrekrutierung (1)
- In-vitro-Kultur (1)
- Individualisierte Medizin (1)
- Infektion (1)
- Inflammation (1)
- Inhibitor (1)
- Insektenstaaten (1)
- Insulin (1)
- Interleukin (1)
- Interleukin 5 (1)
- Interleukin-4 Antagonist (1)
- Intracellular bacteria (1)
- Intrazelluläre Bakterien (1)
- Ischemia (1)
- Karotis-Intima-Media-Dicke (1)
- Kleine Proteine (1)
- Kleinkern (1)
- Knorpel (1)
- Kofaktorbindung (1)
- Kognition (1)
- Kognitive Beeinträchtigung (1)
- Komplement (1)
- Konditionierung (1)
- Konnektivitätsschätzung (1)
- Kopienzahlvariation (1)
- Kraniosynostose (1)
- Krebsforschung (1)
- Kutikula (1)
- Kutikularwachs (1)
- Künstliche Intelligenz (1)
- LPS Biosynthese (1)
- Labeling (1)
- Langerhans cells (1)
- Lasiocarpin (1)
- Latrophilin (1)
- Lebendzellmikroskopie (1)
- Leber-Metabolismus (1)
- Leishmania (1)
- Lenalidomid (1)
- Lernen (1)
- Letalität (1)
- Ligand <Biochemie> (1)
- Lipid Raft (1)
- Lipid Transfer Protein (1)
- Lipide (1)
- Lipolysis (1)
- Lung (1)
- Lunge (1)
- M1 Muscarinic Receptor (1)
- MEK5/ERK5 (1)
- MGMT (1)
- MIZ1 (1)
- MS2-affinity purification and RNA-seq (1)
- Macrophages (1)
- Magnetresonanztomographie (1)
- Makrophage (1)
- Marketing authorisation of pharmaceuticals (1)
- Mauerbiene (1)
- Mechanical deformation (1)
- Mechanismus (1)
- Medium spiny neurons (1)
- Megakaryocyte (1)
- Meninges (1)
- Merkel cell carcinoma (1)
- Merkel cell polyomavirus (1)
- Mesenchymal stem cell (1)
- Mesenchymal stromal cells (1)
- Mesenchymzelle (1)
- Metabolism (1)
- Metabolismus (1)
- Methylierung (1)
- MgrB (1)
- Microglia (1)
- Micronucleus (1)
- Microvesicle (1)
- Mikroglia (1)
- Mitochondria (1)
- Mitochondrien (1)
- Mitochondrium (1)
- Mittelohrimplantat (1)
- Model Organism (1)
- Modellorganismus (1)
- Modellsystem (1)
- Modifizierung (1)
- Monozyt (1)
- Morbus Alzheimer (1)
- Motor learning (1)
- Motorisches Lernen (1)
- Mouse Model (1)
- Mucormykose (1)
- Multiproteinkomplex (1)
- Mundschleimhautzellen (1)
- Muscarinrezeptor (1)
- Mutagenität (1)
- Myb-MuvB complex (1)
- Myeloid (1)
- Myokardinfarkt (1)
- N-Myc (1)
- NK cell (1)
- NK-DC cross-talk (1)
- NRF2 (1)
- NTRK fusions (1)
- Nasenschleimhaut (1)
- Natürliche Killerzelle (1)
- Neisseria gonorrhoeae (1)
- Neuartige Arzneimittel (1)
- Neuralgie (1)
- Neuroanatomie (1)
- Neuroethologie (1)
- Neuroinflammation (1)
- Neuronales visuelles System (1)
- Neuropathie (1)
- Neuropathischer Schmerz (1)
- Neuropeptide (1)
- Neuroprotektivum (1)
- Neuroscience (1)
- Neutrophil (1)
- Neutrophil granulocyte (1)
- Neutrophiler Granulozyt (1)
- Nozizeption (1)
- Nucleotide excision repair (1)
- Nukleotid-Exzisions-Reparatur (1)
- O(6)-Methylguanine-DNA Methyltransferase (1)
- Obesity (1)
- Opiatrezeptor (1)
- Opioide (1)
- Oxidativer Stress (1)
- Oxygen partial pressure (1)
- P4-ATPase (1)
- PAF1c (1)
- PDE (1)
- PRR (1)
- PVM (1)
- Palbociclib (1)
- Parc National de la Comoé (1)
- Parkinson Krankheit (1)
- Parkinson's disease (1)
- Pathogenität (1)
- Pathophysiologie (1)
- Pathophysiologische Mechanismen (1)
- Pattern-Recognition-Receptors (1)
- Persistence (1)
- Pertussis (1)
- Pflanzenaussterben (1)
- Phasenvariation (1)
- Phenotypic switch (1)
- Phosphodiesterase (1)
- Pilzkörper (1)
- PinT (1)
- Plant cuticle (1)
- Plasmamembran (1)
- Plastizität (1)
- Pneumoviruses (1)
- Pollen (1)
- Positronen-Emissions-Tomografie (1)
- Preclinical studies (1)
- Primäre Ziliendyskinesie (1)
- Primärelement (1)
- Primärzellen (1)
- Progenitor (1)
- Protein purification (1)
- Protein-Protein-Interaktion (1)
- Protein-Protein-Wechselwirkung (1)
- Proteinkinase D (1)
- Proteinmodifizierung (1)
- Präklinische Studien (1)
- Präzisionsmedizin (1)
- Psychotherapie (1)
- Punktmutation (1)
- Pyrrolizidinalkaloide (1)
- QPCR (1)
- Qualitätsindikator (1)
- RNS-Interferenz (1)
- RSV (1)
- Receptor dynamics (1)
- Regenerative Medicine (1)
- Regulation (1)
- Regulatorischer T-Lymphozyt (1)
- Resilienz (1)
- Resistance (1)
- Respiratorisches System (1)
- Rezeptorblocker (1)
- Rezidiv (1)
- Rhizopus arrhizus (1)
- Ribonuclease H2 (1)
- Riboregulation (1)
- Risikofaktoren (1)
- Rossameise (1)
- Röntgenkristallographie (1)
- SLC2A3 (1)
- SMN (1)
- Salmonella (1)
- Salmonella Typhimurium (1)
- Scaffold bone implant (1)
- Schimpanse (1)
- Schizosaccharomyces pombe (1)
- Schlaganfall (1)
- Schließzellfunktion (1)
- Secretion (1)
- Sekundäre Inflammation (1)
- Selective extraction (1)
- Senecionin (1)
- Seneciphyllin (1)
- Sequenzwiederholung (1)
- Serotonindefizienz (1)
- Signaltransduktion (1)
- Sleeping Beauty Transposon System (1)
- Small RNA (1)
- Small angle X-ray scattering (1)
- Social action effects (1)
- Sociomotor gaze control (1)
- Soziale Handlungseffekte (1)
- Soziomotorische Blickkontrolle (1)
- SteC (1)
- Sterblichkeit (1)
- Stiff-Person Syndrom (1)
- Stiff-person syndrome (1)
- Stress (1)
- Striatum (1)
- Strukturbiologie (1)
- Superresolution microscopy (1)
- Survival Motor Neuron (1)
- Synaptic plasticity (1)
- Synchronitätsmessung (1)
- T cell engaging Antibody (1)
- TFIIH (1)
- TH2 Immunantwort (1)
- TLR signaling (1)
- Telomerase (1)
- Thebain (1)
- Therapie (1)
- Therapieresistenz (1)
- Thrombopoiesis (1)
- Tight junction (1)
- Tissue engineering (1)
- Toll-like-Rezeptoren (1)
- TraDIS (1)
- Transkription (1)
- Transkriptionsfaktor (1)
- Transkriptomanalyse (1)
- Transkriptomik anlyze (1)
- Transpiration <Pflanzen> (1)
- Transposon (1)
- Treg (1)
- Trend (1)
- Trophic Factors (1)
- Trypanosoma Brucei (1)
- Trypanosoma brucei (1)
- UBE2S (1)
- Ubiquitin-PA (1)
- Ubiquitin-Protein-Ligase (1)
- Ubiquitin-conjugating enzyme (1)
- Ubiquitinierung (1)
- VW-SCs (1)
- Validierung (1)
- Verhalten (1)
- Verhaltenskontrolle (1)
- Very-long-chain aliphatic (1)
- Vesikelbildung (1)
- Vessel wall (1)
- Virtuelle Realität (1)
- Visuelle Aufmerksamkeit (1)
- Vorläufer (1)
- Water stress (1)
- Wirkstoffdesign (1)
- X-ray crystallography (1)
- X-ray diffraction (1)
- Yeast (1)
- Zellzyklus (1)
- Zink-Finger-Proteine (1)
- aGPCR (1)
- acute graft-versus host disease (1)
- adhesion-GPCR (1)
- adrenal gland (1)
- adrenergic receptor (1)
- adrenocortical carcinoma (1)
- airways (1)
- allogeneic stem cell transplantation (1)
- alloreactive T cells (1)
- antimicrobial (1)
- anxiety disorders (1)
- articular cartilage progenitor cells (1)
- atopic diseases (1)
- attributable fraction (1)
- attributable risk (1)
- autoantibody (1)
- autophagocytose (1)
- autophagy (1)
- bacterial lipid rafts (1)
- behavior (1)
- beta-Arrestin2 (1)
- bicuculline (1)
- binding mode (1)
- biochemistry (1)
- biodistribution (1)
- bioimage analysis (1)
- biokinetics (1)
- biolayerinterferometry (1)
- bioreactor (1)
- blood nerve barrier (1)
- bone marrow (1)
- bumblebee*s (1)
- cancer (1)
- candida (1)
- candida albicans (1)
- cartilage (1)
- chlamydia (1)
- chondrogene Differenzierung (1)
- circadian rhythms (1)
- claudin-12 (1)
- co-culture (1)
- cochlea implant (1)
- cofactorbinding (1)
- compartments (1)
- corneal confocal microscopy (1)
- correlation (1)
- cushing's syndrome (1)
- cytokine release syndrome (1)
- cytoskeleton (1)
- dCIRL (1)
- dSTORM (1)
- developmental differentiation (1)
- diabetic cardiomyopathy (1)
- diagnostics (1)
- diastolic dysfunction (1)
- diet (1)
- disease model (1)
- distance (1)
- distribution (1)
- double-strand break repair (1)
- drug repurposing (1)
- dual RNA-seq (1)
- ecology (1)
- effector protein (1)
- electron microscopy (1)
- eosinophil (1)
- evozierte Potentiale (1)
- exposition training (1)
- expression (1)
- extinction dynamics (1)
- fabry disease (1)
- fear conditioning (1)
- fibromyalgia sydrome (1)
- foraging activity (1)
- foxtapeworm (1)
- fragment screening (1)
- functional membrane microdomains (1)
- functional studies (1)
- fungus (1)
- genotoxicity (1)
- germinative cell (1)
- gezielte Therapie (1)
- glycine receptor autoantibodies (1)
- glycophytes (1)
- guard cells (1)
- habitat (1)
- hematopoiesis (1)
- hippocampus (1)
- homoFRET (1)
- honeybee (1)
- honeybee*s (1)
- huh6 (1)
- iPSC (1)
- in vitro Kulturmodelle (1)
- in vitro Testsystem (1)
- interleukin-5 signaling (1)
- internal dosimetry (1)
- interphase gap (1)
- interpulse interval (1)
- intraoperative Ankopplungseffizienz (1)
- kinase (1)
- labeling techniques (1)
- lasiocarpine (1)
- learning (1)
- lipid rafts (1)
- lymph node stromal cells (1)
- lymph node transplantation (1)
- mechanistische Modellierung (1)
- melanoma dedifferentiation (1)
- membrane dynamics (1)
- mesenteric lymph node (1)
- metabolic theory of ecology (1)
- microelectrode array (1)
- mouse models (1)
- mucormycosis (1)
- myelin barrier (1)
- neuroethology (1)
- neuromodulation (1)
- neuronal visual system (1)
- neuropeptides (1)
- neutrophil (1)
- nociception (1)
- nutrients (1)
- nutrition (1)
- p97 (1)
- pain (1)
- pathophysiological mechanisms (1)
- peptide (1)
- peptide engineering (1)
- peptide-based interleukin-5 inhibitor (1)
- perception (1)
- phosphorylation (1)
- platelets (1)
- polarized epithelium (1)
- pollen (1)
- polyethism (1)
- polyradiculoneuropathy (1)
- population attributable fraction (1)
- precision medicine (1)
- preclinical PET (1)
- primary ciliary dyskinesia (1)
- primate (1)
- proboscis extension response (1)
- protease (1)
- protein kinase a (1)
- protein regulation and expression (1)
- protein-protein-interaction (1)
- psychosocial resilience (1)
- rapid evolution (1)
- reception (1)
- receptor (1)
- replication (1)
- resilience (1)
- salinen Wachstumsbedingungen (1)
- salt stress (1)
- schnelle Evolution (1)
- self-activation (1)
- senecionine (1)
- seneciphylline (1)
- shRNA (1)
- signalling (1)
- similarity (1)
- skin (1)
- skin biopsy (1)
- small RNA (1)
- small fiber pathology (1)
- small proteins (1)
- somatic resilience (1)
- somatostatin receptor antagonists (1)
- sphingolipids (1)
- ssVEP (1)
- stiff person syndrome (1)
- structural mechanism (1)
- structure analysis (1)
- super-resolution microscopy (1)
- synaptic plasticity (1)
- synaptische Plastizität (1)
- targeted therapy (1)
- tdcs (1)
- temporal information transfer (1)
- test system (1)
- therapy (1)
- time-resolved anisotropy (1)
- tool (1)
- tool-use (1)
- tracheal cytotoxin (1)
- trachomatis (1)
- transcription/replication conflicts (1)
- transcriptome data analysis (1)
- transcriptomic analysis (1)
- transient dynamics (1)
- tumour (1)
- tyrosine kinase (1)
- virulence (1)
- yeast (1)
- zeitlich Informationsübertragung (1)
- zonal Hydrogels (1)
- µ-Opioid Rezeptor (1)
- Ängstliche Depression (1)
Institute
- Graduate School of Life Sciences (124) (remove)
Sonstige beteiligte Institutionen
- Biomedical Center Munich, Department of Physiological Chemistry, Ludwig-Maximilians-Universität München (1)
- Department of Veterinary Sciences, Experimental Parasitology, Ludwig-Maximilians-Universität München (1)
- Max-Delbrück-Center für molekulare Medizin, Berlin (1)
- Research Center for Infectious Diseases, University of Würzburg (1)
- Spanish National Center for Biotechnology (CNB-CSIC) (1)
- Technische Universität Darmstadt (1)
- University of Applied Sciences Aschaffenburg (1)
- University of Leipzig, Faculty of Life Sciences, Institute for Biology (1)
- Zentrum für Infektionsforschung (ZINF) Würzburg (1)
The greatest problems faced during the 21st century is climate change which is a big threat to food security due to increasing number of people. The increase in extreme weather events, such as drought and heat, makes it difficult to cultivate conventional crops that are not stress tolerant. As a result, increasing irrigation of arable land leads to additional salinization of soils with plant-toxic sodium and chloride ions. Knowledge about the adaptation strategies of salt-tolerant plants to salt stress as well as detailed knowledge about the control of transpiration water loss of these plants are therefore important to guarantee productive agriculture in the future. In the present study, I have characterized salt sensitive and salt tolerant plant species at physiological, phenotypic and transcriptomic level under short (1x salt) and long-time (3x) saline growth conditions. Two approaches used for long-time saline growth conditions (i.e increasing saline conditions (3x salt) and constant high saline conditions (3x 200 mM salt) were successfully developed in the natural plant growth medium i.e soil. Salt sensitive plants, A. thaliana, were able to survive and successfully set seeds at the toxic concentrations on the increasing saline growth mediums, with minor changes in the phenotype. However, under constant high saline conditions they could not survive. This was due to keeping low potassium, and high salt ions (sodium and chloride) in the photosynthetic tissue i.e leaf. Similarly, high potassium and low salt ions in salt tolerant T. salsuginea on both saline environments were the key for survival of this plant species. Being salt tolerant, T. salsuginea always kept high potassium levels and low sodium (during 1x) and chloride levels (during both 1x and 3x) in the leaf tissue.
A strict control over transpirational water loss via stomata (formed by pair of guard cells) is important to maintain plant water balance. Aperture size of the stomata is regulated by the turgidity of the guard cells. More turgid the guard cells, bigger the apertures are and hence more transpiration. Under osmotic stress, the water loss is reduced which was evident in the salt sensitive A. thaliana plants under both short and long-time saline growth conditions. As the osmotic stress was only increased during long time saline growth conditions in T. salsuginea therefore, water loss was also decreased only under these saline conditions. Environmental CO2 assimilation also takes place via stomata in plants which then is used for photosynthesis. Stomatal apertures also influence CO2 assimilation. As the light absorbing photosynthetic pigments were more affected in A. thaliana, therefore photosynthetic activity of the whole plant was also reduced. Similarly, both short and long-time saline growth conditions also reduced the effective quantum yield of A. thaliana guard cells. Growth of the plant is dependent on energy which comes from photosynthesis. Reduced environmental CO2 assimilation would affect photosynthesis and hence growth, which was clearly observed in A. thaliana guard cells under long-time saline growth conditions.
Major differences in both guard cells types were observed in their chloride and potassium levels. Energy Dispersive X-Ray Analysis (EDXA) suggested strict control of chloride accumulation in T. salsuginea guard cells as the levels remain unchanged under all conditions. Similarly, use of sodium in place of potassium for osmotic adjustments seems to be dependent on Na+/K+ rations in both guard cell types. Increased salt ions and reduced potassium levels in A. thaliana guard cells posed negative effect on photochemistry which in turn increased ROS metabolism and reduced energy related pathways at transcriptomic level in this plant species. Moreover, photosynthesis was strongly affected in A. thaliana guard cells both at transcriptomic and physiological levels. Similarly, global phytohormones induced changes were more evident in A. thaliana guard cells especially on 3x salt medium. Among all phytohormones, genes under the control of auxin were more differentially expressed in A. thaliana guard cells which suggests wide changes in growth and development in this plant species under salinity.
Phytohormone, ABA is vital for closing the stomata under abiotic stress conditions. Increased levels of ABA during saline conditions led to efflux of potassium and counter anions (chloride, malate, nitrate) from the guard cells which caused the outward flow of water and hence reduction in turgor pressure. Reduced turgor pressure led to reduced water loss and CO2 assimilation especially in A. thaliana. Guard cells of both plant species synthesized ABA during saline conditions which was reflected from transcriptomic data and ABA quantification in the guard cells. ABA induced signaling in both plant species varied at the ABA receptor (PYL/PYR) levels where totally contrasting responses were observed. PYL2, PYL8 and PYL9 were specific to A. thaliana, furthermore, PYL2 was found to be differentially expressed only under 3x salt growth conditions thus suggesting its role during long term salt stress in this plant species. Protein phosphatases, which negatively regulate ABA signaling on one hand and act as ABA sensor on the other hand were found to be more differentially expressed in A. thaliana than T. salsuginea guard cells, which suggests their diverse role in both plant species under saline conditions. Differential expression of more ABA signaling players in long time saline conditions was prominent which could be because of darkness, as it is well known that rapid closure of stomata under dark conditions require ABA signaling. Moreover, representation of these components in dark also suggests that plants become more sensitive to dark under saline conditions which is also evident from the transpiration rates.
Altogether, increased salt ions in A. thaliana guard cells and leaves led to pigment degradation and ABA induced reduction in transpiration which in turn influenced its growth. In contrast, T. salsuginea is the salt excluder and therefore keeps low levels of salt ions especially the chloride both in leaves and guard cells which mildly affects its growth. Guard cells of A. thaliana encounter severe energy problems at physiological and transcriptomic level. Main differences in the ABA signalling between both plant species were observed at the ABA receptor level.
Summary
Bees, like many other organisms, evolved an endogenous circadian clock, which enables them to foresee daily environmental changes and exactly time foraging flights to periods of floral resource availability. The social lifestyle of a honey bee colony has been shown to influence circadian behavior in nurse bees, which do not exhibit rhythmic behavior when they are nursing. On the other hand, forager bees display strong circadian rhythms. Solitary bees, like the mason bee, do not nurse their offspring and do not live in hive communities, but face the same daily environmental changes as honey bees. Besides their lifestyle mason and honey bees differ in their development and life history, because mason bees overwinter after eclosion as adults in their cocoons until they emerge in spring. Honey bees do not undergo diapause and have a relatively short development of a few weeks until they emerge. In my thesis, I present a comparison of the circadian clock of social honey bees (Apis mellifera) and solitary mason bees (Osmia bicornis and Osmia cornuta) on the neuroanatomical level and behavioral output level.
I firstly characterized in detail the localization of the circadian clock in the bee brain via the expression pattern of two clock components, namely the clock protein PERIOD (PER) and the neuropeptide Pigment Dispersing Factor (PDF), in the brain of honey bee and mason bee. PER is localized in lateral neuron clusters (which we called lateral neurons 1 and 2: LN1 and LN2) and dorsal neuron clusters (we called dorsal lateral neurons and dorsal neurons: DLN, DN), many glia cells and photoreceptor cells. This expression pattern is similar to the one in other insect species and indicates a common ground plan of clock cells among insects. In the LN2 neuron cluster with cell bodies located in the lateral brain, PER is co-expressed with PDF. These cells build a complex arborization network throughout the brain and provide the perfect structure to convey time information to brain centers, where complex behavior, e.g. sun-compass orientation and time memory, is controlled. The PDF arborizations centralize in a dense network (we named it anterio-lobular PDF hub: ALO) which is located in front of the lobula. In other insects, this fiber center is associated with the medulla (accessory medulla: AME). Few PDF cells build the ALO already in very early larval development and the cell number and complexity of the network grows throughout honey bee development. Thereby, dorsal regions are innervated first by PDF fibers and, in late larval development, the fibers grow laterally to the optic lobe and central brain. The overall expression pattern of PER and PDF are similar in adult social and solitary bees, but I found a few differences in the PDF network density in the posterior protocerebrum and the lamina, which may be associated with evolution of sociality in bees.
Secondly, I monitored activity rhythms, for which I developed and established a device to monitor locomotor activity rhythms of individual honey bees with contact to a mini colony in the laboratory. This revealed new aspects of social synchronization and survival of young bees with indirect social contact to the mini colony (no trophalaxis was possible). For mason bees, I established a method to monitor emergence and locomotor activity rhythms and I could show that circadian emergence rhythms are entrainable by daily temperature cycles. Furthermore, I present the first locomotor activity rhythms of solitary bees, which show strong circadian rhythms in their behavior right after emergence. Honey bees needed several days to develop circadian locomotor rhythms in my experiments. I hypothesized that honey bees do not emerge with a fully matured circadian system in the hive, while solitary bees, without the protection of a colony, would need a fully matured circadian clock right away after emergence. Several indices in published work and preliminary studies support my hypothesis and future studies on PDF expression in different developmental stages in solitary bees may provide hard evidence.
The adaptive immune system is known to provide highly specific and effective immunity against a broad variety of pathogens due to different effector cells. The most prominent are CD4+ T-cells which differentiate after activation into distinct subsets of effector and memory cells, amongst others T helper 1 (Th1) cells. We have recently shown that mouse as well as human Th1 cells depend on T cell receptor (TCR) signals concomitant with CD28 costimulation in order to secrete interferon (IFN) which is considered as their main effector function. Moreover, there is a class of anti-CD28 monoclonal antibodies that is able to induce T cell (re-)activation without concomitant TCR ligation. These so-called CD28-superagonists (CD28-SA) have been shown to preferentially activate and expand CD4+ Foxp3+ regulatory T (Treg) cells and thereby efficaciously conferring protection e.g. against autoimmune responses in rodents and non-human primates. Considering this beneficial effect, CD28-SA were thought to be of great impact for immunotherapeutic approaches and a humanized CD28-SA was subjected to clinical testing starting with a first-in-man trial in London in 2006. Unexpectedly, the volunteers experienced life-threatening side effects due to a cytokine release syndrome (CRS) that was unpredicted by the preclinical studies prior to the trial. Retrospectively, CD4+ memory T cells within the tissues were identified as source of pro-inflammatory cytokines released upon CD28-SA administration. This was not predicted by the preclinical testing indicating a need for more reliable and predictive animal models. Whether mouse CD4+ T cells are generally irresponsive to CD28-SA stimulation or rather the lack of a bona fide memory T cell compartment in cleanly housed specific-pathogen-free (SPF) mice is the reason why the rodent models failed to predict the risk for a CRS remained unclear. To provide SPF mice with a true pool of memory/effector T cells, we transferred in vitro differentiated TCR-transgenic OT-II Th1 cells into untreated recipient mice. Given that Treg cells suppress T cell activation after CD28- SA injection in vivo, recipients were either Treg-competent or Treg-deficient, wild type or DEREG mice, respectively. Subsequent CD28-SA administration resulted in induction of systemic pro-inflammatory cytokine release, dominated by IFN, that was observed to be much more pronounced and robust in Treg-deficient recipients. Employing a newly established in vitro system mirroring the in vivo responses to CD28-SA stimulation of Th1 cells revealed that antigen-presenting cells (APCs) amplify CD28-SAinduced IFN release by Th1 cells due to CD40/CD40L-interactions. Thus, these data are the first to show that mouse Th1 cells are indeed sensitive to CD28-SA stimulation in vivo and in vitro responding with strong IFN release accompanied by secretion of further pro-inflammatory cytokines, which is compatible with a CRS. In conclusion, this study will facilitate preclinical testing of immunomodulatory agents providing a mouse model constituting more “human-like” conditions allowing a higher degree of reliability and translationability.
The cytokine interleukin-5 (IL-5) is part of the TH2-mediated immune response. As a key regulator of eosinophilic granulocytes (eosinophils), IL-5 controls multiple aspects of eosinophil life. Eosinophils play a pathogenic role in the onset and progression of atopic diseases as well as hypereosinophilic syndrome (HES). Here, cytotoxic proteins and pro-inflammatory mediators stored in intracellular vesicles termed granula are released upon activation thereby causing local inflammation to fight the pathogen. However, if such inflammation persists, tissue damage and organ failure can occur. Due to the close relationship between eosinophils and IL-5 this cytokine has become a major pharmaceutical target for the treatment of atopic diseases or HES. As observed with other cytokines, IL-5 signals by assembling a heterodimeric receptor complex at the cell surface in a stepwise mechanism. In the first step IL-5 binds to its receptor IL-5Rα (CD125). This membrane-located complex then recruits the so-called common beta chain βc (CD131) into a ternary ligand receptor complex, which leads to activation of intracellular signaling cascades. Based on this mechanism various strategies targeting either IL-5 or IL-5Rα have been developed allowing to specifically abrogate IL-5 signaling. In addition to the classical approach of employing neutralizing antibodies against IL 5/IL-5Rα or antagonistic IL-5 variants, two groups comprising small 18 to 30mer peptides have been discovered, that bind to and block IL-5Rα from binding its activating ligand IL-5. Structure-function studies have provided detailed insights into the architecture and interaction of IL-5IL-5Rα and βc. However, structural information for the ternary IL-5 complex as well as IL-5 inhibiting peptides is still lacking.
In this thesis three areas were investigated. Firstly, to obtain insights into the second receptor activation step, i.e. formation of the ternary ligand-receptor complex IL-5•IL-5Rα•βc, a high-yield production for the extracellular domain of βc was established to facilitate structure determination of the ternary ligand receptor assembly by either X-ray crystallography or cryo-electron microscopy.
In a second project structure analysis of the ectodomain of IL-5Rα in its unbound conformation was attempted. Data on IL-5Rα in its ligand-free state would provide important information as to whether the wrench-like shaped ectodomain of IL-5Rα adopts a fixed preformed conformation or whether it is flexible to adapt to its ligand binding partner upon interaction. While crystallization of free IL-5Rα failed, as the crystals obtained did not diffract X rays to high resolution, functional analysis strongly points towards a selection fit binding mechanism for IL-5Rα instead of a rigid and fixed IL-5Rα structure. Hence IL-5 possibly binds to a partially open architecture, which then closes to the known wrench-like architecture. The latter is then stabilized by interactions within the D1-D2 interface resulting in the tight binding of IL-5.
In a third project X-ray structure analysis of a complex of the IL-5 inhibitory peptide AF17121 bound to the ectodomain of IL-5Rα was performed. This novel structure shows how the small cyclic 18mer peptide tightly binds into the wrench-like cleft formed by domains D1 and D2 of IL-5Rα. Due to the partial overlap of its binding site at IL-5Rα with the epitope for IL-5 binding, the peptide blocks IL-5 from access to key residues for binding explaining how the small peptide can effectively compete with the rather large ligand IL-5. While AF17121 and IL-5 seemingly bind to the same site at IL-5Rα, functional studies however showed that recognition and binding of both ligands differ. With the structure for the peptide-receptor complex at hand, peptide design and engineering could be performed to generate AF17121 analogies with enhanced receptor affinity. Several promising positions in the peptide AF17121 could be identified, which could improve inhibition capacity and might serve as a starting point for AF17121-based peptidomimetics that can yield either superior peptide based IL-5 antagonists or small-molecule-based pharmacophores for future therapies of atopic diseases or the hypereosinophilic syndrome.
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder with an estimated heritability of around 70%. In order to fully understand ADHD biology it is necessary to incorporate multiple different types of research. In this thesis, both human and animal model research is described as both lines of research are required to elucidate the aetiology of ADHD and development new treatments. The role of a single gene, Adhesion G protein-coupled receptor L3 (ADGRL3) was investigated using a knockout mouse model. ADGRL3 has putative roles in neuronal migration and synapse function. Various polymorphisms in ADGRL3 have been linked with an increased risk of attention deficit/hyperactivity disorder (ADHD) in human studies. Adgrl3-deficient mice were examined across multiple behavioural domains related to ADHD: locomotive activity, visuospatial and recognition memory, gait impulsivity, aggression, sociability and anxiety-like behaviour. The transcriptomic alterations caused by Adgrl3-depletion were analysed by RNA-sequencing of three ADHD-relevant brain regions: prefrontal cortex (PFC), hippocampus and striatum. Increased locomotive activity in Adgrl3-/- mice was observed across all tests with the specific gait analysis revealing subtle gait abnormalities. Spatial memory and learning domains were also impaired in these mice. Increased levels of impulsivity and sociability accompanying decreased aggression were also detected. None of these alterations were observed in Adgrl3+/- mice. The numbers of genes found to exhibit differential expression was relatively small in all brain regions sequenced. The absence of large scale gene expression dysregulation indicates a specific pathway of action, rather than a broad neurobiological perturbation. The PFC had the greatest number of differentially expressed genes and gene-set analysis of differential expression in this brain region detected a number of ADHD-relevant pathways including dopaminergic synapses as well as cocaine and amphetamine addiction. The most dysregulated gene in the PFC was Slc6a3 which codes for the dopamine transporter, a molecule vital to current pharmacological treatment of ADHD. The behavioural and transcriptomic results described in this thesis further validate Adgrl3 constitutive knockout mice as an experimental model of ADHD and provide neuroanatomical targets for future studies involving ADGRL3 modified animal models.
The study of ADHD risk genes such as ADGRL3 requires the gene to be first identified using human studies. These studies may be genome based such as genome wide association studies (GWAS) or transcriptome based using microarray or RNA sequencing technology. To explore ADHD biology in humans the research described in this thesis includes both GWAS and trancriptomic data. A two-step transcriptome profiling was performed in peripheral blood mononuclear cells (PBMCs) of 143 ADHD subjects and 169 healthy controls. We combined GWAS and expression data in an expression-based Polygenic Risk Score (PRS) analysis in a total sample of 879 ADHD cases and 1919 controls from three different datasets. Through this exploratory study we found eight differentially expressed genes in ADHD and no support for the genetic background of the disorder playing a role in the aberrant expression levels identified. These results highlight promising candidate genes and gene pathways for ADHD and support the use of peripheral tissues to assess gene expression signatures for ADHD.
This thesis illustrates how both human and animal model research is required to increase our understanding of ADHD. The animal models provide biological insight into the targets identified in human studies and may themselves provide further relevant gene targets. Only by combining research from disparate sources can we develop the thorough understanding on ADHD biology required for treatment development, which is the ultimate goal of translational science research.
Obesity-induced diabetes affects over 400 million people worldwide. Obesity is a complex metabolic disease and is associated with several co-morbidities, all of which negatively affect the individual’s quality of life. It is commonly considered that obesity is a result of a positive energy misbalance, as increased food intake and lower expenditure eventually lead to the development of this disease. Moreover, the pathology of obesity is attributed to several genetic and epigenetic factors that put an individual at high risk compared to another. Adipose tissue is the main site of the organism’s energy storage. During the time when the nutrients are available in excess, adipocytes acquire triglycerides, which are released during the time of food deprivation in the process of lipolysis (free fatty acids and glycerol released from adipocytes). Uncontrolled lipolysis is the consequent event that contributes to the development of diabetes and paradoxically obesity. To identify the genetic factors aiming for future therapeutic avenues targeting this pathway, we performed a high-throughput screen and identified the Extracellular-regulated kinase 3 (ERK3) as a hit. We demonstrate that β-adrenergic stimulation stabilizes ERK3 leading to the formation of a complex with the co-factor MAP kinase-activated protein kinase 5 (MK5) thereby driving lipolysis. Mechanistically, we identify a downstream target of the ERK3/MK5 pathway, the transcription factor FOXO1, which promotes the expression of the major lipolytic enzyme ATGL. Finally, we provide evidence that targeted deletion of ERK3 in mouse adipocytes inhibits lipolysis, but elevates energy dissipation, promoting lean phenotype and ameliorating diabetes. Moreover, we shed the light on our pharmacological approach in targeting ERK3/MK5 pathways using MK5 specific inhibitor. Already after 1 week of administering the inhibitor, mice showed signs of improvement of their metabolic fitness as showed here by a reduction in induced lipolysis and the elevation in the expression of thermogenic genes. Taken together, our data suggest that targeting the ERK3/MK5 pathway, a previously unrecognized signaling axis in adipose tissue, could be an attractive target for future therapies aiming to combat obesity-induced diabetes.
DD is a cardiac disturbance, which has gained increasing importance in recent years due to its important role in different cardiac disease and cardiomyopathies including ischemic cardiomyopathy, arterial hypertension and diabetic cardiomyopathy.
ECG-gated 18F-FDG PET is an imaging technique, that can distinguish between districts of myocardial viability and myocardial scars and further provides information of great interest on the efficacy of experimental approaches designed to improve the cardiac function and/or myocardial metabolism in experimental small animal models. However, ECG-gated 18F-FDG PET is a technique whose feasibility in the assessment of the LV diastolic function in small animals has not been a subject of study.
In this thesis, the ability of the ECG-gated 18F-FDG PET for the assessment of both the systolic and diastolic function in eight control rats and in seven ZDF rats, which are an experimental animal model mimicking T2DM conditions and diabetic related complications in humans including DCM, has been investigated The ECG-gated 18F-FDG PET imaging was performed under hyperinsulinemic-euglycemic clamping and the data were stored in list mode files and retrospectively reconstructed. The systolic and diastolic parameters were achieved from the time/volume and the time/filling curve calculated from the software HFV. Additionally, the influence of the number of gates per cardiac cycle on the LV volumes and function parameters has been studied.
Hyperinsulinemic-euglycemic clamp procedure and blood glucose measurement did confirm the development of a manifest diabetes in the ZDF rats at the timepoint of the experiments.
Regarding the systolic parameters, no significant difference could be detected between the ZDF and ZL rats. The values for the CO were similar in both groups, which demonstrates a similar LV systolic function in the ZDF and the ZL rats at the age of 13 weeks. Values for the systolic parameters are in good line with previous PET, MRI and cardiac catheterization-based studies in diabetic rats.
The main finding of this study was that by using in vivo ECG-gated 18F-FDG PET and the software HFV, reliable diastolic parameters could be calculated. Moreover, it was possible to detect the presence of a mild impaired diastolic filling in the ZDF rats in absence of any systolic alteration. This impaired diastolic function in an early stage of diabetes could also be detected by other investigators, who used echocardiography or cardiac catheterization. Therefore, this is the first study showing, that the assessment of the diastolic function in rats can be carried out by ECG-gated 18F-FDG PET imaging.
In conclusion, additionally to calculating LV volumes and LV EF, ECG-gated 18F-FDG PET can evaluate the diastolic function of healthy and diabetic rats and is able to detect a DD in ZDF rats.
Die WHO-Klassifikation der Hirntumoren von 2016 ebnete den Weg für molekulare Marker und Therapie-Angriffspunkte. Der Transkriptionsfaktor ATF5 könnte ein solcher sein. Er unterdrückt die Differenzierung von neuronalen Vorläuferzellen und wird in Glioblastomen (GBM) überexprimiert. Daten zur ATF5-Expression in WHO Grad II Gliomen (LGG) und GBM-Rezidiven sind nur spärlich vorhanden. Daher untersuchten wir 79 GBM, 40 LGG und 10 Normalhirnproben auf ihre ATF5-mRNA- und Proteinexpression mit quantitativer Echtzeit-PCR bzw. Immunhistochemie und verglichen sie mit multiplen, retrospektiv erhobenen klinischen Charakteristika der Patienten. ATF5 war in LGG und GBM verglichen zum Normalhirn sowohl auf mRNA-, als auch Proteinebene überexprimiert. Obwohl die ATF5-mRNA-Expression im GBM eine erhebliche Fluktuationsrate zeigte, gab es keine signifikanten Expressionsunterschiede zwischen GBM-Gruppen unterschiedlicher biologischer Wachstumsmuster. ATF5-mRNA korrelierte mit dem Alter der Patienten und invers mit der Ki67-Färbung. Kaplan Meier- und Cox-Regressionsanalysen zeigten eine signifikante Korrelation der ATF5-mRNA-Expression mit dem Überleben nach 12 Monaten sowie dem progressionsfreien Überleben. Die Methylierung des Promotors der O6-Methylguanin-DNA-Methyltransferase (MGMT) ist ein etablierter Marker in der Therapie des GBMs. Sie ist mit dem therapeutischen Ansprechen auf Temozolomid und dem Überleben assoziiert. Uns fielen inzidentell Veränderungen der MGMT-Promotormethylierung auf, woraufhin wir den aktuellen Wissensstand mittels einer ausführlichen Literatur-Metaanalyse zusammenfassten. Dabei fanden wir Veränderungen der MGMT-Promotormethylierung bei 115 der 476 Patienten. Wir schlussfolgern, dass die ATF5-mRNA-Expression als prognostischer Faktor für das Überleben der Patienten dienen könnte. Da seine in vitro-Inhibition zu einem selektiven Zelltod von Gliomzellen führte und wir eine Überexpression in glialen Tumoren nachweisen konnten, zeigt ATF5 Potential als ubiquitäres Therapieziel in Gliomen. Zum aktuellen Zeitpunkt ergibt sich keine klare Indikation, den klinischen Standard der MGMT-Teststrategie zu verändern. Trotzdem könnte eine erneute Testung der MGMT-Promotormethylierung für zukünftige Therapieentscheidungen sinnvoll sein und wir regen an, dass dieses Thema in klinischen Studien weiter untersucht wird.
Neuroblastoma is the most abundant, solid, extracranial tumor in early childhood and the leading cause of cancer-related childhood deaths worldwide. Patients with high-risk neuroblastoma often show MYCN-amplification and elevated levels of Aurora-A. They have a low overall survival and despite multimodal therapy options a poor therapeutic prognosis. MYCN-amplified neuroblastoma cells depend on Aurora-A functionality. Aurora-A stabilizes MYCN and prevents it from proteasomal degradation by competing with the E3 ligase SCFFBXW7. Interaction between Aurora-A and MYCN can be observed only in S phase of the cell cycle and activation of Aurora-A can be induced by MYCN in vitro. These findings suggest the existence of a profound interconnection between Aurora-A and MYCN in S phase. Nevertheless, the details remain elusive and were investigated in this study.
Fractionation experiments show that Aurora-A is recruited to chromatin in S phase in a MYCN-dependent manner. Albeit being unphosphorylated on the activating T288 residue, Aurora-A kinase activity was still present in S phase and several putative, novel targets were identified by phosphoproteomic analysis. Particularly, eight phosphosites dependent on MYCN-activated Aurora-A were identified. Additionally, phosphorylation of serine 10 on histone 3 was verified as a target of this complex in S phase. ChIP-sequencing experiments reveal that Aurora-A regulates transcription elongation as well as histone H3.3 variant incorporation in S phase. 4sU-sequencing as well as immunoblotting demonstrated that Aurora-A activity impacts splicing. PLA measurements between the transcription and replication machinery revealed that Aurora-A prevents the formation of transcription-replication conflicts, which activate of kinase ATR.
Aurora-A inhibitors are already used to treat neuroblastoma but display dose-limiting toxicity. To further improve Aurora-A based therapies, we investigated whether low doses of Aurora-A inhibitor combined with ATR inhibitor could increase the efficacy of the treatment albeit reducing toxicity. The study shows that the combination of both drugs leads to a reduction in cell growth as well as an increase in apoptosis in MYCN-amplified neuroblastoma cells, which is not observable in MYCN non-amplified neuroblastoma cells. This new approach was also tested by a collaboration partner in vivo resulting in a decrease in tumor burden, an increase in overall survival and a cure of 25% of TH-MYCN mice. These findings indicate indeed a therapeutic window for targeting MYCN-amplified neuroblastoma.
In dieser Dissertation wird der MEK5/ERK5- Signalweg als möglicher Angriffspunkt in der zielgerichteten Melanomtherapie identifiziert. Die Adressierung von ERK5 bietet eine Alternative, um einer Resistenzentwicklung gegenüber Inhibitoren des MAPK- Signalwegs entgegenzuwirken. Das maligne Melanom ist ein hochaggressiver Tumor mit steigender Inzidenz. Zunehmende Sonnenstunden im Rahmen des Klimawandels mit erhöhter Belastung der Haut durch UV-Strahlung werden die Problematik des malignen Melanoms für den Menschen in den nächsten Jahren weiter zunehmen lassen.
Die Aktivierung des MEK5/ERK5- Signalwegs scheint eine Reaktion von Tumorzellen auf Therapiestress zu sein. Diese Aktivierung liefert den Melanomzellen einen Überlebensvorteil und verhindert ein langfristiges Therapieansprechen. ERK5 beeinflusst den Zellzyklus von Melanomzellen und ist somit möglicherweise von wichtiger Bedeutung in der Tumorgenese des malignen Melanoms.
Patienten mit NRAS- Mutation profitieren auffallend weniger von einer gezielten MEKi-Therapie als solche mit BRAF Mutation. Für ersteres Patientenkollektiv steht aktuell lediglich die Immuntherapie zur Verfügung, wodurch oft nur ein kurzes, progressionsfreies Intervall erreicht werden kann und die Patienten häufig unter schweren Nebenwirkungen leiden. Grund für die problematische Behandlung könnte das häufige Auftreten einer basalen ERK5- Aktivierung in NRAS- mutierten Melanomen sein. Diese Arbeit liefert eine positive Prognose über den Nutzen einer ERK5- Inhibition als Erweiterung des Therapieschemas. Diese These gilt auch für Melanompatienten mit einer BRAF- Mutation. Patienten, die an einem malignen Melanom erkrankt sind, weisen zu 80% eine Mutation in einem dieser beschriebenen Onkogene auf. Die Arbeit lässt darauf schließen, dass eine ERK5- Inhibition in der Therapie von beiden Gruppen erfolgreich sein könnte und somit das Leben nahezu aller Melanompatienten betrifft.